Ask AI
ProCE Banner Series

From Today to Tomorrow: the Evolving Clinical Role of CELMoD Agents in Multiple Myeloma

This educational program will review the mechanistic rationale and emerging clinical data supporting CELMoD development across the multiple myeloma treatment continuum, with emphasis on evolving efficacy and safety data, ongoing investigations, and practical considerations surrounding treatment sequencing and future clinical integration.

Key Takeaways

  • Review unmet needs and evolving treatment landscape for relapsed/refractory multiple myeloma, including the role of novel targeted protein degradation approaches
  • Discuss key mechanistic distinctions and emerging clinical data for CELMoD-based regimens, including efficacy and safety considerations
  • Consider practical strategies for treatment sequencing, patient selection, and integration of CELMoD agents within the broader multiple myeloma treatment paradigm

All Events

From Today to Tomorrow: the Evolving Clinical Role of CELMoD Agents in Multiple Myeloma

Upcoming Events

July

09

2026

12:15 PM - 1:00 PM Eastern Time (ET)

Virtual